Albireo Pharma, Inc. (ALBO) Social Stream



Albireo Pharma, Inc. (ALBO): $20.70

0.65 (+3.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Albireo Pharma Inc (ALBO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Albireo Pharma Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 6 $84 $67 $76.5 $32.39 136.18%
2022-02-23 5 $84 $67 $75.8 $32.39 134.02%
2022-03-04 5 $84 $67 $74.2 $32.39 129.08%
2022-03-28 5 $80 $68 $73.75 $32.39 127.69%

The Trend in the Analyst Price Target


ALBO's average price target has moved up $22.25 over the prior 23 months.

ALBO reports an average of 147.84% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 4 82 65 72.86 29.91 143.6%
2021-06-05 4 82 67 73.43 30.56 140.28%
2021-07-17 4 82 67 73.43 35.25 108.31%
2021-08-01 4 82 68 75.86 28.61 165.15%
2021-11-08 5 84 67 75.80 29.71 155.13%

ALBO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 151 days, ALBO's average broker recommendation rating improved by 0.5.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how Albireo Pharma Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 497.43% of that group.
  • Albireo Pharma Inc's average analyst price target is higher than 575.55% of stocks in the small market cap category.
  • ALBO has a lower variance in analysts' estimates than 9.37% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Albireo Pharma Inc's number of analysts covering the stock is higher than 397.2% of them.

In the Pharmaceutical Products industry, AKUS, AKRO, and AKBA are the three stocks most similar to Albireo Pharma Inc regarding the price target and analyst recommendation information presented here.

Is ALBO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7076 seconds.